JP2024519082A - 肝細胞がんのdnaメチル化バイオマーカー - Google Patents

肝細胞がんのdnaメチル化バイオマーカー Download PDF

Info

Publication number
JP2024519082A
JP2024519082A JP2023571830A JP2023571830A JP2024519082A JP 2024519082 A JP2024519082 A JP 2024519082A JP 2023571830 A JP2023571830 A JP 2023571830A JP 2023571830 A JP2023571830 A JP 2023571830A JP 2024519082 A JP2024519082 A JP 2024519082A
Authority
JP
Japan
Prior art keywords
cancer
methylation
dmr
patient
samples
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023571830A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024519082A5 (https=
Inventor
リール,ホセ ペレイラ
ヴァズ,ジョアナ カルドソ
ゴンサルベス,エマニュエル ホセ ヴィエイラ
レイス,マリア アナ ゴンサルベス
Original Assignee
オフィオミクス-インベスティガカオ イー デセンボルヴィメント エン バイオテクノロジア エスエー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オフィオミクス-インベスティガカオ イー デセンボルヴィメント エン バイオテクノロジア エスエー filed Critical オフィオミクス-インベスティガカオ イー デセンボルヴィメント エン バイオテクノロジア エスエー
Publication of JP2024519082A publication Critical patent/JP2024519082A/ja
Publication of JP2024519082A5 publication Critical patent/JP2024519082A5/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20Supervised data analysis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Software Systems (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Evolutionary Computation (AREA)
  • Public Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2023571830A 2021-05-21 2022-05-23 肝細胞がんのdnaメチル化バイオマーカー Pending JP2024519082A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21175425 2021-05-21
EP21175425.4 2021-05-21
PCT/EP2022/063902 WO2022243566A1 (en) 2021-05-21 2022-05-23 Dna methylation biomarkers for hepatocellular carcinoma

Publications (2)

Publication Number Publication Date
JP2024519082A true JP2024519082A (ja) 2024-05-08
JP2024519082A5 JP2024519082A5 (https=) 2025-05-21

Family

ID=76059821

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023571830A Pending JP2024519082A (ja) 2021-05-21 2022-05-23 肝細胞がんのdnaメチル化バイオマーカー

Country Status (5)

Country Link
US (1) US20240229158A1 (https=)
EP (1) EP4341441A1 (https=)
JP (1) JP2024519082A (https=)
CN (1) CN117355616A (https=)
WO (1) WO2022243566A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120584199A (zh) * 2023-01-26 2025-09-02 乐彼代株式会社 用于预测发展肝癌风险的组合物
TWI911076B (zh) * 2024-04-22 2026-01-01 雲享投資顧問有限公司 早期肝細胞癌的檢測方法及在該方法中使用的試劑套組

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9984201B2 (en) 2015-01-18 2018-05-29 Youhealth Biotech, Limited Method and system for determining cancer status
WO2017048932A1 (en) 2015-09-17 2017-03-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Cancer detection methods
CN113151458A (zh) 2016-07-06 2021-07-23 优美佳肿瘤技术有限公司 实体瘤甲基化标志物及其用途
WO2018009705A1 (en) 2016-07-06 2018-01-11 Youhealth Biotech, Limited Liver cancer methylation markers and uses thereof
EP3507298B1 (en) * 2016-09-02 2023-08-30 Mayo Foundation for Medical Education and Research Detecting hepatocellular carcinoma
BR112019018272A2 (pt) * 2017-03-02 2020-07-28 Youhealth Oncotech, Limited marcadores metilação para diagnosticar hepatocelular carcinoma e câncer
KR102103885B1 (ko) 2019-10-08 2020-04-24 주식회사 레피다인 생물학적 시료의 간 조직 유래 여부를 판별하는 방법
CN112037863B (zh) * 2020-08-26 2022-06-21 南京医科大学 一种早期nsclc预后预测系统

Also Published As

Publication number Publication date
WO2022243566A1 (en) 2022-11-24
CN117355616A (zh) 2024-01-05
EP4341441A1 (en) 2024-03-27
US20240229158A1 (en) 2024-07-11

Similar Documents

Publication Publication Date Title
CN112159844B (zh) 结直肠癌dna甲基化的检测方法及试剂
JP2022539443A (ja) メチル化核酸の高深度シーケンシングのための方法とシステム
JP7665659B2 (ja) 循環腫瘍核酸分子のマルチモーダル分析
EP3034624A1 (en) Method for the prognosis of hepatocellular carcinoma
JP2009528825A (ja) デュークスb大腸がんの再発を予測するための分子的解析
US10457988B2 (en) MiRNAs as diagnostic markers
CN103502473A (zh) 胃肠胰神经内分泌肿瘤(gep-nen)的预测
WO2015073949A1 (en) Method of subtyping high-grade bladder cancer and uses thereof
AU2017281099A1 (en) Compositions and methods for diagnosing lung cancers using gene expression profiles
AU2015317893A1 (en) Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
US20250137066A1 (en) Compostions and methods for diagnosing lung cancers using gene expression profiles
US20240229158A1 (en) Dna methylation biomarkers for hepatocellular carcinoma
AU2018428853B2 (en) Methods and compositions for the analysis of cancer biomarkers
US20250179583A1 (en) Methylated dna markers and assays thereof for use in detecting colorectal cancer
US12592321B2 (en) Cancer detection and classification using methylome analysis
US20250163514A1 (en) Epigenetic biomarkers for the diagnosis of thyroid cancer
Michel et al. Non-invasive multi-cancer diagnosis using DNA hypomethylation of LINE-1 retrotransposons
HK40092784A (zh) 循环肿瘤核酸分子的多模态分析
JP2025537530A (ja) Dnaメチル化プロファイルの高感度かつ特異的な判定
KR20230037111A (ko) 대사증후군 특이적 후성유전 메틸화 마커 및 이의 용도
HK40035251B (en) Detection methods and reagents for dna methylation of colorectal cancer
HK40035251A (en) Detection methods and reagents for dna methylation of colorectal cancer

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250513

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250513